1. An economic evaluation of the randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo (the HI‐Light Vitiligo Trial)*. (1st May 2021) Authors: Sach, T.H.; Thomas, K.S.; Batchelor, J.M.; Perways, A.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An economic evaluation of the randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo (the HI‐Light Vitiligo Trial). (1st May 2021) Authors: Sach, T.H.; Thomas, K.S.; Batchelor, J.M.; Perways, A.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An economic evaluation of the randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo (the HI‐Light Vitiligo Trial). (4th November 2020) Authors: Sach, T.H.; Thomas, K.S.; Batchelor, J.M.; Perways, A.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case–control diagnostic accuracy study (DIPSOC study). (1st February 2022) Authors: Burden‐Teh, E.; Murphy, R.; Gran, S.; Nijsten, T.; Hughes, C.; Abdul‐Wahab, A.; Bewley, A.; Burrows, N.; Darne, S.; Gach, J.E.; Katugampola, R.; Jury, C.S.; Kuet, K.; Llewellyn, J.; McPherson, T.; Ravenscroft, J.C.; Taibjee, S.; Wilkinson, C.; Thomas, K.S. Journal: British journal of dermatology Issue: Volume 186:Number 2(2022) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case–control diagnostic accuracy study (DIPSOC study). (24th November 2021) Authors: Burden‐Teh, E.; Murphy, R.; Gran, S.; Nijsten, T.; Hughes, C.; Abdul‐Wahab, A.; Bewley, A.; Burrows, N.; Darne, S.; Gach, J.E.; Katugampola, R.; Jury, C.S.; Kuet, K.; Llewellyn, J.; McPherson, T.; Ravenscroft, J.C.; Taibjee, S.; Wilkinson, C.; Thomas, K.S. Journal: British journal of dermatology Issue: Volume 186:Number 2(2022) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey. (1st March 2016) Authors: Wedgeworth, E.; Glover, M.; Irvine, A.D.; Neri, I.; Baselga, E.; Clayton, T.H.; Beattie, P.E.; Bjerre, J.V.; Burrows, N.P.; Foelster‐Holst, R.; Hedelund, L.; Hernandez‐Martin, A.; Audrain, H.; Bhate, K.; Brown, S.J.; Baryschpolec, S.; Darne, S.; Durack, A.; Dvorakova, V.; Gach, J. Journal: British journal of dermatology Issue: Volume 174:Number 3(2016) Page Start: 594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey3. (26th December 2015) Authors: Wedgeworth, E.; Glover, M.; Irvine, A.D.; Neri, I.; Baselga, E.; Clayton, T.H.; Beattie, P.E.; Bjerre, J.V.; Burrows, N.P.; Foelster‐Holst, R.; Hedelund, L.; Hernandez‐Martin, A.; Audrain, H.; Bhate, K.; Brown, S.J.; Baryschpolec, S.; Darne, S.; Durack, A.; Dvorakova, V.; Gach, J. Journal: British journal of dermatology Issue: Volume 174:Number 3(2016) Page Start: 594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial*. (1st May 2021) Authors: Thomas, K.S.; Batchelor, J.M.; Akram, P.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Sach, T.H.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N.J. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial. (1st May 2021) Authors: Thomas, K.S.; Batchelor, J.M.; Akram, P.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Sach, T.H.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N.J. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial. (28th December 2020) Authors: Thomas, K.S.; Batchelor, J.M.; Akram, P.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Sach, T.H.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N.J. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗